PAVM
Price
$0.77
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:37 PM (EDT)
Capitalization
17.23M
RVTY
Price
$94.19
Change
+$0.51 (+0.54%)
Updated
Apr 24, 02:47 PM (EDT)
Capitalization
12.76B
4 days until earnings call
Ad is loading...

PAVM vs RVTY

Header iconPAVM vs RVTY Comparison
Open Charts PAVM vs RVTYBanner chart's image
PAVmed
Price$0.77
Change-$0.00 (-0.00%)
Volume$200
Capitalization17.23M
Revvity
Price$94.19
Change+$0.51 (+0.54%)
Volume$500
Capitalization12.76B
PAVM vs RVTY Comparison Chart
Loading...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAVM vs. RVTY commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAVM is a StrongBuy and RVTY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (PAVM: $0.77 vs. RVTY: $93.68)
Brand notoriety: PAVM and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PAVM: 87% vs. RVTY: 149%
Market capitalization -- PAVM: $17.23M vs. RVTY: $12.76B
PAVM [@Medical Specialties] is valued at $17.23M. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAVM’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • PAVM’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, PAVM is a better buy in the long-term than RVTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAVM’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 5 bullish TA indicator(s).

  • PAVM’s TA Score: 5 bullish, 4 bearish.
  • RVTY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both PAVM and RVTY are a good buy in the short-term.

Price Growth

PAVM (@Medical Specialties) experienced а +7.65% price change this week, while RVTY (@Medical Specialties) price change was -1.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

PAVM is expected to report earnings on Mar 24, 2025.

RVTY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than PAVM($17.2M). PAVM YTD gains are higher at: 22.709 vs. RVTY (-15.953). RVTY has higher annual earnings (EBITDA): 714M vs. PAVM (-75.74M). RVTY has more cash in the bank: 1.6B vs. PAVM (19.6M). PAVM has less debt than RVTY: PAVM (48.7M) vs RVTY (4.07B). RVTY has higher revenues than PAVM: RVTY (2.75B) vs PAVM (2.45M).
PAVMRVTYPAVM / RVTY
Capitalization17.2M12.8B0%
EBITDA-75.74M714M-11%
Gain YTD22.709-15.953-142%
P/E RatioN/A71.72-
Revenue2.45M2.75B0%
Total Cash19.6M1.6B1%
Total Debt48.7M4.07B1%
FUNDAMENTALS RATINGS
PAVM vs RVTY: Fundamental Ratings
PAVM
RVTY
OUTLOOK RATING
1..100
155
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
4790
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAVM's Valuation (50) in the Medical Specialties industry is in the same range as RVTY (65). This means that PAVM’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as PAVM (100). This means that RVTY’s stock grew similarly to PAVM’s over the last 12 months.

RVTY's SMR Rating (85) in the Medical Specialties industry is in the same range as PAVM (100). This means that RVTY’s stock grew similarly to PAVM’s over the last 12 months.

PAVM's Price Growth Rating (63) in the Medical Specialties industry is in the same range as RVTY (64). This means that PAVM’s stock grew similarly to RVTY’s over the last 12 months.

PAVM's P/E Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for RVTY (90). This means that PAVM’s stock grew somewhat faster than RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAVMRVTY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 4 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Ad is loading...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JOBY6.160.27
+4.58%
Joby Aviation
UGRO0.470.01
+2.41%
urban-gro
WRB71.240.39
+0.55%
WR Berkley Corp
BGS7.02-0.05
-0.71%
B&G Foods
DC2.75-0.05
-1.79%
Dakota Gold Corp

PAVM and

Correlation & Price change

A.I.dvisor tells us that PAVM and GMED have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
+10.00%
GMED - PAVM
26%
Poorly correlated
+2.47%
CVRX - PAVM
25%
Poorly correlated
+1.33%
RVTY - PAVM
25%
Poorly correlated
+1.46%
CSTL - PAVM
24%
Poorly correlated
-3.32%
FLGT - PAVM
24%
Poorly correlated
+2.49%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with IQV. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
+1.46%
IQV - RVTY
66%
Closely correlated
+2.40%
CRL - RVTY
63%
Loosely correlated
+1.97%
A - RVTY
62%
Loosely correlated
+2.13%
TMO - RVTY
62%
Loosely correlated
-0.71%
BIO - RVTY
60%
Loosely correlated
+1.58%
More